There are 5 papers on plasma GFAP in aging research: 1 trial and 3 observational studies in people, 1 review.
5 papers study it80 more mention it9 findings
3 new papers in 30 daysSee all 85 papers on plasma GFAP
“higher plasma GFAP levels were significantly associated with increased odds of poor sleep (OR=1.67, 95% CI[1.03, 2.70], p = .036)”
- Human trial1
- Humans3
Interventions
1Okinawa-based Nordic diet
downin humans1
1 study
Okinawa-based Nordic diet
downin humans1
Okinawa-based Nordic diet decreases plasma GFAP in humans (type 2 diabetes).
Human trialtype 2 diabetes3 monthsn = 30
Associations
8Sleep latency
upin humans1OR 1.18
1 study
Sleep latency
upin humans1OR 1.18
Plasma GFAP is associated with sleep latency in humans (cognitively unimpaired) (OR=1.18, 95% CI[1.07, 1.30], p = .001).
Humanscognitively unimpairedplasman = 1,801
Poor sleep
upin humans1OR 1.67
1 study
Poor sleep
upin humans1OR 1.67
Plasma GFAP is associated with poor sleep in humans (cognitively unimpaired) (OR=1.67, 95% CI[1.03, 2.70], p = .036).
Humanscognitively unimpairedplasman = 1,801
Islet amyloid polypeptide
upin humans1
1 study
Islet amyloid polypeptide
upin humans1
Plasma GFAP is associated with islet amyloid polypeptide in humans (type 2 diabetes; baseline; adjusted for age, sex, and body mass index) (r = 0.478).
Humanstype 2 diabetes; baseline; adjusted for age, sex, and body mass indexn = 30
Proinflammatory plasma cytokines
upin humans1
1 study
Proinflammatory plasma cytokines
upin humans1
Plasma GFAP is associated with proinflammatory plasma cytokines in humans (type 2 diabetes; baseline; adjusted for age, sex, and body mass index) (r = 0.440 to r = 0.530).
Humanstype 2 diabetes; baseline; adjusted for age, sex, and body mass indexn = 30
Neurofilament light polypeptide
upin humans1
1 study
Neurofilament light polypeptide
upin humans1
Plasma GFAP is associated with neurofilament light polypeptide in humans (type 2 diabetes; baseline) (r = 0.400).
Humanstype 2 diabetes; baselinen = 30
Cognitive impairment
upin humans1
1 study
Cognitive impairment
upin humans1
Plasma GFAP is associated with cognitive impairment in humans (Autosomal dominant Alzheimer's disease).
HumansAutosomal dominant Alzheimer's disease
Neurodegeneration
upin humans1
1 study
Neurodegeneration
upin humans1
Plasma GFAP is associated with neurodegeneration in humans (Autosomal dominant Alzheimer's disease).
HumansAutosomal dominant Alzheimer's disease
Amyloid-beta load
upin humans1
1 study
Amyloid-beta load
upin humans1
Plasma GFAP is associated with amyloid-beta load in humans.
HumansAutosomal dominant Alzheimer's disease; stronger association in asymptomatic than symptomatic participants
Funding
1 grant since 2023Alzheimer's Association